LPNT:NGS-LifePoint Health Inc.

EQUITY | Health Care Providers | Nasdaq Global Select

Last Closing

USD 64.99

Change

0.00 (0.00)%

Market Cap

USD 2.25B

Volume

1.16M

Analyst Target

USD 65.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

LifePoint Health Inc is a healthcare company dedicated to Making Communities Healthier. The Company through its subsidiaries owns & operates community hospitals, regional health systems, physician practices, outpatient centers, & post-acute facilities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Health Care Providers

ETFs Containing LPNT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Care Providers) Market Performance vs. Exchange (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 34.00% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.00% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 5.83% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.83% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.88% 29% F 29% F
Dividend Return -0.88% 29% F 26% F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) 20.05% 94% A 63% D
Risk Adjusted Return -4.38% 29% F 26% F
Market Capitalization 2.25B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Health Care Providers) Ratio vs. Market (Nasdaq Global Select)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 19.50 N/A N/A
Price/Book Ratio 59.22 N/A N/A
Price / Cash Flow Ratio 4.50 N/A N/A
Price/Free Cash Flow Ratio 19.00 N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.